This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Omnicell Launches G4 Unity Platform At ASHP 2012

Stocks in this article: OMCL

MOUNTAIN VIEW, Calif., Dec. 3, 2012 /PRNewswire/ --  Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced its Omnicell G4 Unity platform at the American Society for Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition in Las Vegas, NV.

(Logo:  http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

The G4 Unity platform features a single, shared medication database that connects all G4 Unity solutions to enable complete medication and supply tracking from the controlled substance vault to medication and supply cabinets, the OR and to the bedside. The unified database also helps to eliminate redundant data entry that can lead to errors. The platform is powered by the enterprise-class OmniCenter® server, which centrally manages Omnicell medication and supply dispensing systems and now stores up to seven years of data, enabling quick retrieval and analysis of extended historical information. The ability to store seven years of data is a critical and growing compliance factor in several U.S. states. G4 Unity solutions leverage robust software, computing power and hardware from Microsoft, Intel and Dell. The consistent look and feel of the G4 Unity solution user interface simplifies workflow tasks for busy healthcare providers. 

The G4 Unity platform offers capabilities that enhance the user experience, and provides a foundation for ongoing innovations to keep pace with changing regulatory and workflow requirements. In addition, the G4 Unity solutions allow hospitals to connect to electronic health records and other healthcare information systems to improve functionality and simplify system administration.

Omnicell will introduce a number of product enrichments at ASHP. Among these new enhancements is the latest release of Omnicell's Controlled Substance Management System (CSM) which provides electronic facility-wide ordering of controlled substances from the Drug Enforcement Administration's Controlled Substance Ordering System and wholesalers based on established par and reorder points. The automated receiving process improves the accuracy of medication costs and drug information introduced into the system. The robust ordering and receiving functionality streamlines controlled substance inventory demands to a single purchasing platform, providing a system-wide view of inventory usage and medication expenditures.

Omnicell will also demonstrate the latest release of Anywhere RN™ remote medication management software. Anywhere RN provides clinicians unmatched, state-of-the-art functionality. For example, in direct response to customer input, the latest version features enhanced privacy for patient data and more flexible options including the ability to configure remote wasting.

With the new software release, Omnicell has also enhanced the existing medication and supply dispensing technology for the long-term non-acute care market by adding the ability to support multiple time zones from a single server. This allows users such as institutional pharmacies to streamline operations, reduce costs and simplify reporting.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs